Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes. Oiwa A, Hiwatashi D, Takeda T, Miyamoto T, et al. J Clin Endocrinol Metab 2023 Mar 14:dgad144. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Oiwa A, Hiwatashi D, Takeda T, Miyamoto T, et al. Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes. J Clin Endocrinol Metab 2023 Mar 14:dgad144. doi: 10.1210.
PMID: 36916985